Blood TCRs go to town with early NPC detection

In this issue of Cancer Cell, Zhang et al. report an innovative approach utilizing patients’ blood T cell receptor (TCR) sequences for the early detection of nasopharyngeal cancer. This study highlights the potential of harnessing highly public TCRs in the peripheral blood as biomarkers for virally associated malignancies.

Read the full article here

Related Articles

Home: Cell Press

Publisher of over 50 scientific journals across the life, physical, earth, and health sciences, both independently and in partnership with scientific societies including Cell, Neuron,…